|
|
|
Finansų valdymas |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tarptautinis verslas 3 kurso 1 grupė |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Atvejų
analizė sąrašas |
|
|
|
|
|
|
|
Prezentacijos
pateikimo savalaikiškumas, skaidrių kokybė, oratorinis menas,
auditorijos įtraukimas į atvejo analizę 0-3 |
Analizuojamos
problemos sudėtingumas 0-3 |
Atvejo
analizės platumas, t.y. pakankamai daug atlikta darbo 0-4 |
Atvejo
analizės gilumas, t.y. panaudoti sudėtingi analizės metodai
0-4 |
Surinkta
papildoma, įdomi ir vertinga medžiaga
0-2 |
Apibendrinimas,
išvados, kas įsimintina, kuo vertingas pateiktas atvejis, kur galima
pritaikyti įgytas žinias 0-2 |
Testo klausimų kokybė 0-2 |
Oponavimas arba
aktyvus dalyvavimas analizuojant atvejus 0-1 |
|
|
| Eil
Nr. |
Pusl. |
Pavadinimas |
Dalyviai
/ Oponentai |
Pristatymo data |
Pristatymo
eilė |
Pristatymo
skaidrės |
Papildoma medžiaga 1 |
Papildoma medžiaga 2 |
Vertinimas |
| 1 |
365-369 |
Valuing Capital investment Projects |
Lukas Žilius |
|
|
|
|
|
9 |
2 |
2 |
2 |
|
1 |
1 |
|
1 |
| |
365-370 |
Valuing Capital investment Projects |
Maksimilijanas Ponomariovas |
|
|
|
|
|
9 |
2 |
2 |
2 |
|
1 |
1 |
|
1 |
| |
365-369 |
Valuing Capital investment Projects |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 2 |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
Aidas Kristupas Jonynas |
|
|
|
|
|
8 |
3 |
2 |
1 |
|
1 |
1 |
|
|
| |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
371-376 |
Merck & Company: Evaluating a Drug Licensing Opportunity |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 4 |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
377-379 |
Tree Values |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 5 |
381-394 |
The Super Project |
Dovilė Kairytė |
|
|
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
| |
381-394 |
The Super project |
Monika Stankevičiūtė |
|
|
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
| |
381-394 |
The Super project |
Eglė Matulytė |
|
|
|
|
|
10 |
3 |
2 |
2 |
|
1 |
1 |
|
1 |
| 6 |
395-403 |
Net Flix |
Ieva Bakanaitė |
|
|
|
|
|
10 |
3 |
2 |
2 |
|
1 |
2 |
|
|
| |
395-403 |
Net Flix |
Raminta Saletytė |
|
|
|
|
|
10 |
3 |
2 |
2 |
|
1 |
2 |
|
|
| |
395-403 |
Net Flix |
Karolina Šuopytė |
|
|
|
|
|
11 |
3 |
2 |
2 |
|
1 |
2 |
|
1 |
| 7 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
Sofija Sokolova |
|
|
|
|
|
10 |
2 |
2 |
2 |
1 |
2 |
1 |
|
|
| |
405-418 |
A-Rod: Signing the Best Player in Baseball |
Rytis Bimbiras |
|
|
|
|
|
11 |
2 |
2 |
2 |
1 |
2 |
1 |
|
1 |
| |
405-418 |
A-Rod: Signing the Best Player in Baseball |
Tomas Labašauskas |
|
|
|
|
|
10 |
2 |
2 |
2 |
1 |
2 |
1 |
|
|
| 8 |
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
405-418 |
A-Rod: Signing the Best Player in Baseball |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 9 |
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 10 |
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
419-423 |
Ocean Carriers |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 11 |
405-418 |
Whirlpool Europe |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 12 |
405-418 |
Whirlpool Europe |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
405-418 |
Whirlpool Europe |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
405-418 |
Whirlpool Europe |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 13 |
431-434 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 14 |
431-435 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 15 |
431-436 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 16 |
431-437 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 17 |
431-438 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 18 |
431-439 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 19 |
431-440 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 20 |
431-441 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 8 |
431-442 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
431-443 |
Health Development Corporation |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
257 |
The Investment Detective
(Investment criteria and discounted cash flow) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
259 |
Worldwide Paper Company
(Analysis of an expansion investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 9 |
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Rūta Vyšniauskaitė |
|
|
|
|
|
9 |
3 |
2 |
2 |
|
1 |
1 |
|
|
| |
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Ieva Miliauskaitė |
|
|
|
|
|
9 |
3 |
2 |
2 |
|
1 |
1 |
|
|
| |
263 |
Target Corporation
(Multifaceted capital investment decisions) |
Ignė Elinauskaitė |
|
|
|
|
|
9 |
3 |
2 |
2 |
|
1 |
1 |
|
|
| 10 |
283 |
Aurora Textile Company
(Analysis of an automation investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
283 |
Aurora Textile Company
(Analysis of an automation investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
283 |
Aurora Textile Company
(Analysis of an automation investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
295 |
Compass Records (Analysis
of working capital investment) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 11 |
309 |
Victoria Chemicals plc (A): The Merseyside Project (Relevant cash flows) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Karolis Znaidauskas |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Alfredas Noreika |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
317 |
Victoria Chemicals plc (B): Merseyside and Rotterdam
Projects (Mutually exclusive
investment opportunities) |
Dovydas Balčiūnas |
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
325 |
Euroland Foods S.A.
(Strategic resource allocation) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| |
337 |
Star River Electronics Ltd.(Capital project analysis and
forecasting) |
|
|
|
|
|
|
0 |
|
|
|
|
|
|
|
|
| 1 |
277-296 |
Introduction to Derivative Instruments |
Andrius Lesevičius |
|
|
|
|
|
9 |
3 |
2 |
|
2 |
1 |
1 |
|
|
| 2 |
277-296 |
Introduction to Derivative Instruments |
|
|
|
|
|
|
9 |
3 |
2 |
|
2 |
1 |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|